Table 1.
HBC% pos. Population | THP-1% pos. Population | |||||||
---|---|---|---|---|---|---|---|---|
Untreated | LPS + INF-γ | IL-4 + IL-13 | p-Value | Untreated | LPS + INF-γ | IL-4 + IL-13 | p-Value | |
CD163 | 82.9 ± 13.7 | 67.7 ± 31.5 | 79.0 ± 11.5 | 70.3 ± 24.7 | 91.5 ± 4.9 | 78.0 ± 18.4 | ||
CD206 | 76.7 ± 18.4 | 27.6 ± 6.6** | 81.0 ± 4.7 | ** 0.01 | 2.7 ± 1.5 | 6.2 ± 0.7* | 2.7 ± 1.7 | *0.02 |
DC-SIGN | 77.7 ± 11.4 | 26.9 ± 16.4* | 93.1 ± 2.7 | * 0.03 | 41.4 ± 10.5 | 34.7 ± 15.6 | 57.0 ± 32.2* | *0.01 |
CD80 | 40.4 ± 20.4 | 32.8 ± 14.0 | 42.0 ± 20.2 | 4.9 ± 3.5 | 46.9 ± 18.5* | 3.2 ± 1.9 | *0.03 | |
CD86 | 67.6 ± 18.1 | 50.1 ± 14.0 | 72.8 ± 11.3 | 24.8 ± 8.1 | 61.2 ± 19.7* | 23.1 ± 9.8 | *0.02 | |
TLR1 | 31.4 ± 24.4 | 26.6 ± 11.3 | 34.7 ± 19.3 | 14.1 ± 5.7 | 16.1 ± 5.3 | 7.7 ± 3.6* | *0.04 | |
TLR4 | 96.0 ± 3.6 | 84.6 ± 13.1 | 91.7 ± 4.3 | 74.3 ± 14.1 | 93.2 ± 12.0 | 66.3 ± 16.5 | ||
HLA-DR | 74.8 ± 16.1 | 62.8 ± 12.8 | 77.5 ± 10.4 | 64.9 ± 13.7 | 95.8 ± 7.2** | 43.8 ± 8.9* | **0.005; *0.025 | |
VEGF | 94.4 ± 6.5 | 88.8 ± 7.9 | 92.1 ± 7.8 | 96.8 ± 1.8 | 99.3 ± 0.5 | 96.8 ± 2.5 |